- Generic name
- Sacubitril + Valsartan
- Strength
- 24 mg + 26 mg
- Dosage form
- Tablet
- Manufactured by
- The ACME Laboratories Ltd.
Sacuva 50 Tablet
About Sacuva 50 24 mg + 26 mg Tablet
Sacuva 50 24 mg + 26 mg tablet is a medicine made by The ACME Laboratories Ltd. Sacuva 50 is used to treat chronic heart failure with reduced ejection fraction in adults.
There are 25 brands of Sacubitril + Valsartan listed in Bangladesh. The lowest listed price is Arnis 24 mg+26 mg Tablet at ৳ 35.00 per unit.
What is Sacuva 50 24 mg + 26 mg Tablet?
The tablet Sacuva 50 contains Sacubitril + Valsartan and is made by The ACME Laboratories Ltd. Together they are used in the treatment of heart failure. Sacuva 50 is a tablet medicine that combines two active substances: sacubitril and valsartan. Use it only as your doctor directs.
Uses of Sacuva 50
Sacuva 50 is used to treat chronic heart failure with reduced ejection fraction in adults. It is not a general heart tonic and is not meant for people without a heart failure diagnosis. Sacuva 50 is used to lower the risk of death from heart problems and hospitalization in adults with long-term heart failure and a reduced pumping action of the heart. Ask your doctor whether it is right for your condition.
How to use Sacuva 50
Swallow the tablet whole with water; do not crush or chew it. Sacuva 50 is taken by mouth. Take Sacuva 50 exactly as prescribed by your doctor. Do not stop taking it without medical advice, even if you feel better, because the doctor has planned the course for your heart condition. The doctor decides the dose and how long you need it.
Side effects of Sacuva 50
Swelling of the face or throat, difficulty breathing, or fainting need urgent medical help. Like other medicines, Sacuva 50 can cause side effects. Tell your doctor promptly if you notice swelling, difficulty breathing, or a big drop in blood pressure. Tell your doctor or pharmacist if you notice any side effects or if they bother you.
Safety and precautions
Before taking Sacuva 50, tell your doctor if you have a history of angioedema or if you are allergic to any of its ingredients. Safety in children under one year is not established. Do not use Sacuva 50 if you are allergic to any of its ingredients, or if you have had angioedema related to an ACE inhibitor or an ARB, or have hereditary angioedema. Keep out of reach of children.
Frequently asked questions
What does Sacuva 50 treat?
Sacuva 50 is used to treat chronic heart failure with reduced ejection fraction in adults. It is not a general heart tonic and is not meant for people without a heart failure diagnosis.
How do I use Sacuva 50 correctly?
Swallow the tablet whole with water; do not crush or chew it. Sacuva 50 is taken by mouth.
Can Sacuva 50 cause side effects?
Swelling of the face or throat, difficulty breathing, or fainting need urgent medical help. Like other medicines, Sacuva 50 can cause side effects.
Can I use Sacuva 50 in pregnancy or while breastfeeding?
Before taking Sacuva 50, tell your doctor if you have a history of angioedema or if you are allergic to any of its ingredients. Safety in children under one year is not established.
Indications
- To reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class ll-IV) and reduced ejection fraction.
- For the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older. ... Read more
- To reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class ll-IV) and reduced ejection fraction.
- For the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older.
- This is usually administered in conjunction with other heart failure therapies, in place of an angiotensin-converting enzyme inhibitor (ACEi) or other ARB.
Pharmacology
Dosage & Administration
Reduce the starting dose to 24/26 mg twice daily for:
- Patients not currently taking an angiotensin-converting enzyme inhibitor (ACEi) or an angiotensin II receptor blocker (ARB) or previously taking a low dose of these agents.
- Patients with severe renal impairment.
- Patients with moderate hepatic impairment.
Recommended Dose Titration-
Pediatric Patients Less than 40 kg:
- Starting: 1.6 mg/kg
- Second: 2.3 mg/kg
- Final: 3.1 mg/kg
- Starting: 24/26 mg
- Second: 49/51 mg
- Final: 49/51 mg
- Starting: 49/51 mg
- Second: 72/78 mg
- Final: 97/103 mg
Interaction
Potassium-sparing Diuretics: Serum potassium level may be increased.
NSAIDs: Risk of renal impairment may be increased.
Lithium: Increased risk of lithium toxicity.
Contraindications
- In patients with hypersensitivity to any component
- In patients with a history of angioedema related to previous ACE inhibitor or ARB therapy
- With concomitant use of ACE inhibitors. Do not administer within 36 hours of switching from or to an ACE inhibitor
- With concomitant use of aliskiren in patients with diabetes
Side Effects
Pregnancy & Lactation
Geriatric Use: No relevant pharmacokinetic differences have been observed in elderly (>65 years) or very elderly (>75 years) patients compared to the overall population.
Hepatic Impairment: No dose adjustment is required when administering this tablet to patients with mild hepatic impairment (Child-Pugh A classification). This tablet is not recommended in patients with severe hepatic impairment, as no studies have been conducted in these patients.
Renal Impairment: No dose adjustment is required in patients with mild (eGFR 60 to 90 ml/min/1.73 m2) to moderate (eGFR 30 to 60 ml/min/1.73 m2) renal impairment. The recommended starting dose in patients with severe renal impairment (eGFR <30 ml/min/1.73 m2) is 24/26 mg twice daily.
Precautions & Warnings
This tablet lowers blood pressure and may cause symptomatic hypotension. Closely monitor serum creatinine, and down-titrate or interrupt this tablet in patients who develop a clinically significant decrease in renal function. In patients with renal artery stenosis, monitor renal function.
Monitor serum potassium periodically and treat appropriately, especially in patients with risk factors for hyperkalemia such as severe renal impairment, diabetes, hypoaldosteronism, or a high potassium diet. Dosage reduction or interruption of this tablet may be required.
Overdose Effects
Storage Conditions
Alternative brands of Sacubitril + Valsartan
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.